Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Oct;8(4):375–378. doi: 10.1111/j.1365-2125.1979.tb04725.x

Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.

M A Reveley, V Glover, M Slander, A Coppen
PMCID: PMC1429837  PMID: 508514

Full text

PDF
375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berrettini W. H., Vogel W. H. Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia. Am J Psychiatry. 1978 May;135(5):605–607. doi: 10.1176/ajp.135.5.605. [DOI] [PubMed] [Google Scholar]
  2. Coppen A., Ramo Rao V. A., Swade C., Wood K. Zimelidine: a therapeutic and pharmacokinetic study in depression. Psychopharmacology (Berl) 1979 Jun 21;63(3):199–202. doi: 10.1007/BF00433549. [DOI] [PubMed] [Google Scholar]
  3. Davidson J., Mcleod M. N., Linnoila M., Kurland A. A., White H. L. Platelet MAO inhibition following tricyclic antidepressant therapy. Am J Psychiatry. 1978 May;135(5):603–605. doi: 10.1176/ajp.135.5.603. [DOI] [PubMed] [Google Scholar]
  4. Friedhoff A. J., Miller J. C., Karpatkin S. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. Blood. 1978 Feb;51(2):317–323. [PubMed] [Google Scholar]
  5. Fuller R. W., Hemrick S. K., Mills J. Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine. Biochem Pharmacol. 1978;27(18):2255–2261. doi: 10.1016/0006-2952(78)90085-0. [DOI] [PubMed] [Google Scholar]
  6. Glover V., Sandler M., Owen F., Riley G. J. Dopamine is a monoamine oxidase B substrate in man. Nature. 1977 Jan 6;265(5589):80–81. doi: 10.1038/265080a0. [DOI] [PubMed] [Google Scholar]
  7. Green A. L., el Hait M. A. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo. J Pharm Pharmacol. 1978 Apr;30(4):262–263. doi: 10.1111/j.2042-7158.1978.tb13223.x. [DOI] [PubMed] [Google Scholar]
  8. PHILLIPS A. W., NEWCOMB H. R., RUPP F. A., LACHAPELLE R. Nutritional and microbial effects on liver monoamine oxidase and serotonin in the chick. J Nutr. 1962 Feb;76:119–123. doi: 10.1093/jn/76.2.119. [DOI] [PubMed] [Google Scholar]
  9. Robinson D. S., Nies A., Ravaris C. L., Ives J. O., Bartlett D. Clinical pharmacology of phenelzine. Arch Gen Psychiatry. 1978 May;35(5):629–635. doi: 10.1001/archpsyc.1978.01770290111010. [DOI] [PubMed] [Google Scholar]
  10. Roth J. A., Gillis C. N. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine. Biochem Pharmacol. 1974 Sep 15;23(18):2537–2545. doi: 10.1016/0006-2952(74)90176-2. [DOI] [PubMed] [Google Scholar]
  11. Sullivan J. L., Dackis C., Stanfield C. In vivo inhibition of platelet MAO activity by tricyclic antidepressants. Am J Psychiatry. 1977 Feb;134(2):188–190. doi: 10.1176/ajp.134.2.188. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES